Table 1.
Patient characteristics
| Gender | |
| Male | 54 (42%) |
| Female | 75 (58%) |
| Extracranial tumor activity | |
| Yes | 39 |
| No | 90 |
| Diagnosis of brain metastases within 30 days after diagnosis of primary tumor | |
| Yes | 39 |
| No | 90 |
| Prior brain treatment | |
| Yes | 23 |
| No | 106 |
| Prior SRS | |
| Yes | 15 |
| No | 114 |
| Prior WBRT | |
| Yes | 7 |
| No | 122 |
| Prior surgery | |
| Yes | 8 |
| No | 121 |
| Prior systemic treatment | |
| Yes | 76 |
| No | 53 |
| Presence of extracranial metastases | |
| Yes | 54 |
| No | 75 |
| Presence of lymph node metastases | |
| Yes | 68 |
| No | 61 |
| Presence of seizure | |
| Yes | 18 |
| No | 111 |
| KPS score | |
| 60 | 3 |
| 70 | 14 |
| 80 | 31 |
| 90 | 38 |
| 100 | 43 |
| Occurrence of new metastases after GKRS | |
| Yes | 62 |
| No | 67 |
| Presence of local recurrence | |
| Yes | 40 |
| No | 89 |
| Total tumor volume (mm3) | |
| Average | 17,445 (88–88,029 mm3) |
| Treatment dose (Gy) | |
| Average (minimum–maximum) | 22 (18–25) |
| Age at diagnosis of brain metastases (years) | |
| Average (minimum–maximum) | 63 (36–85) |
| Primary tumor type | |
| Lung | 89 |
| Melanoma | 8 |
| Breast | 3 |
| Others | 29 |
| Number of brain metastases | |
| 1 | 30 |
| 2–3 | 50 |
| 4–10 | 41 |
| > 10 | 8 |